Volume : 11, Issue : 01, January – 2024
Title:
A REVIEW ON PILOT PLANT SCALE UP TECHNIQUES AND PLATFORM TECHNOLOGY
Authors :
B.Mahammad Thowsif*, Dr. BV.Ramana
Abstract :
In modern context, as per market demand there is surely an augmentation or decrease in production, this is called SUPAC. Distinct recommendations are made for those diverse sorts of SUPAC in by various regulating organizations for manufacture of items. Here SUPAC guidelines and post approval adjustments are provided for production in this review study. determined that SUPAC guideline line offer benefits as: This Review Focus on Reduced processing period for site transfers, saving operational overhead & maintenance expenditures. More quicker deployment of equipment and method improvements, better yield & Reduce failure investigations. More quicker adoption, increase in lot sizes and Manufacture of fewer un commercial stability batches and Reducing stability testing/costs.
Keywords : Pilot plant techniques ,solid dosage form, tablet compression, SUPAC, Post approval changes, Lot size , Site Transfer, Stability.
Cite This Article:
Please cite this article in press B.Mahammad Thowsif et al., A Review On Pilot Plant Scale Up Techniques And Platform Technology, Indo Am. J. P. Sci, 2024; 11 (01).
Number of Downloads : 10
References:
1. Roop K Khar, Farhan J Ahmad, A Vashishtha, S. Harder, GV Buskirk, JV Battista. Pilot Plant Scale-up and Production Management. In: Roop K Khar, SP Vyas, Farhan J Ahmad, Gaurav K Jain, Editors. Industrial Pharmacy. 4 th edition. New Delhi: CBS Publishers &Distributors Pvt Ltd, 2013. pp. 947-1002.
2. Dhobale AV, Mahale AM, Shirsat M, Pethkar S, Chakote V. Recent Advances in Pilot Plant Scale Up Techniques – A Review. Indo Am J Pharm Res 2018; 8(4): 1060-1068.
3. Gomez AL, Strathy WA. Engineering Aspects of Process Scale-Up and Pilot Plant Design.In: Michael Levin, editor. PharmaceuticalProcess Scale-Up. New York: Marcel Dekker Inc;2002. p. 311-324.
4. Shah VP, Skelly JP, Barr WH, Malinowski H, Amidon GL. Scale-up of Controlled ReleaseProducts – Preliminary Considerations. Pharm Technol 1992; 16(5):35-40.
5. FDA. Center for Drug Evaluation and Research,Guidance for Industry: Immediate Release Solid OralDosage Forms. Scale-up and Post-Approval Changes:Chemistry, Manufacturing and Controls, In VitroDissolution Testing, and In Vivo BioequivalenceDocumentation [SUPAC-IR]; 1995.
6. Mounica NVN, Sharmila RV, Anusha S, Evangeline L, Nagabhushanam MV, Nagarjunareddy D, et al. Scale up and Postapproval changes (SUPAC) Guidance for Industry: A Regulatory note. Int J Drug RegulAff 2017; 5(1): 13-19.
7. Sherman R. Technology & Product Architectures. In: Business Intelligence Guidebook. Science Direct; 2015.
8. S. Henricks. The Possibilities and Challenges of Spray Drying, Advancing Process Solution Pharmaceutical Technology, Europe, Reprinted May 2010.
9. Vyas SP, Khar RK. Controlled Drug Delivery: Concepts and Advances. Lasted. Vallabh prakashan, 2002,156-189.
10. Shargel L, Yu ABC. Modified release drug products. In: Applied
11. Biopharmaceutics and Pharmacokinetics. 4th ed. McGraw Hill. 1999; 169-171.
12. Ratner BD, Kwok C. Characterization of delivery systems, surface analysis and controlled release systems. In: Encyclopaedia of Controlled Drug Delivery, Vol-I. Published by John Wiley & sons. 1999; 349-362.
13. Nandita GD, Sudip KD. Controlled-release of oral dosage forms, Formulation, Fill and Finish 2003, 10-16.
14. Malamataris S, Karidas T, Goidas P. Effect of particle size and sorbed moisture on the compression behaviour of some hydroxypropyl methylcellulose (HPMC) polymers, Int J Pharm 1994, 103, 205-215.
15. Gohel MC, Parikh RK, Padshala MN, Jena GD. Formulation and optimization of directly compressible isoniazid modified release matrix tablet, Int J Pharm Sci 2007, 640-644.
16. Levina M, Palmer F, Rajabi-Siahboomi A. Investigation of directly compressible metformine HCl 500 mg extended release formulation based on hypromellose, Controlled Release Society Annual Meeting 2005, 1-3.